However, dysfunctional CD14+CD16+ subset not only affect Aβ clearance in AD but also may lead to reduction of IL-10, which is an anti-inflammatory cytokine and protective factor for neurogenesis and cognitive preservation, thus exacerbating the pathogenesis of AD14. Here, CD14 is linked to Alzheimer disease.